News Database

All AI drug discovery news — deals, press releases, papers, and media coverage — in one searchable archive.

Showing 1–20 of 4,287 entries
May 11, 2026
Press
CFO transition announcedBenevolentAI
benevolent.com
May 11, 2026
Paper
Synthesizability-aware reinforcement learning for multi-parameter optimizationSegler, Coley, Jensen · Chem. Sci.
pubs.rsc.org
May 10, 2026
Media
AI drug discovery stocks cool after Recursion guide-downSector commentary
Bloomberg
May 10, 2026
Paper
Active-learning loops with wet-lab feedback reduce hit-to-lead cycles to 8 weeksKim, Sanchez, Zavoronkov et al.
Nature Biotech.
May 10, 2026
Press
XFEP platform scales to 1M compounds/dayXtalPi
xtalpi.com
May 10, 2026
Media
FDA's new AI guidance draft: what drug developers need to knowRegulatory
STAT News
May 9, 2026
Deal
Relay Therapeutics — RLY-2608 Phase 3 ReDiscover-2 opensRelay Therapeutics · Milestone
relaytx.com
May 9, 2026
Paper
Clinical-trial digital twins from EHR foundation models reduce sample size by 30%Perez, Huang, Topol · Nat. Med.
nature.com
May 9, 2026
Media
Foundation models for chemistry: what they do — and don't — replaceEditorial
Nature Biotech.
May 8, 2026
Press
ABCL-101 IND clearanceAbCellera
abcellera.com
May 8, 2026
Press
Strategic review updateEvotec
evotec.com
May 8, 2026
Paper
ProteinMPNN-X: zero-shot design of enzymes with catalytic tetradsWatson, Zhang, Baker · Science
science.org
May 8, 2026
Media
Relay's PI3Kα mutant-selective drug heads into Phase 3 with best-in-class tolerability dataClinical
FierceBiotech
May 7, 2026
Deal
Recursion / Roche-Genentech — $150M neuroscience collaborationRecursion · Collaboration
recursion.com
May 7, 2026
Press
AlphaFold-based generative suite v3 launchedIsomorphic Labs
isomorphiclabs.com
May 7, 2026
Paper
Scaling structure-conditioned generative chemistry to 10⁹ compounds with pocket-aware flow matchingNguyen, Patel, Kovacs et al. · Nature
nature.com
May 7, 2026
Media
Insilico's fibrosis drug delivers — and so does the model behind itClinical
STAT News
May 7, 2026
Media
Recursion-Roche expansion: bigger check, narrower focusDeal analysis
Endpoints
May 6, 2026
Deal
Insilico Medicine / Qilu Pharmaceutical — $120M licensingInsilico · Licensing
insilico.com
May 6, 2026
Press
LiveDesign 2026.1 releaseSchrödinger
schrodinger.com
May 6, 2026
Press
REC-4881 Phase 2 initiates in FAPRecursion
recursion.com
May 6, 2026
Paper
De novo design of allosteric PROTAC linkers using contrastive language-structure modelsLi, Okafor, Shah · Nat. Chem. Biol.
nature.com
May 5, 2026
Press
INS018_055 Phase 2b topline data in IPFInsilico Medicine
insilico.com
May 5, 2026
Press
Q1 2026 results: revenue up 38% YoYTempus AI
tempus.com
May 5, 2026
Paper
A foundation model for target identification from multi-omic perturbation atlasesAlvarez, Chen, Rood et al. · Cell
cell.com

The definitive searchable archive of AI drug discovery news since 2024.